El-Asrar AM - Search Results

1

Retinopathy as a predictor of other diabetic complications.

El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D. El-Asrar AM, et al. Int Ophthalmol. 2001;24(1):1-11. doi: 10.1023/a:1014409829614. Int Ophthalmol. 2001. PMID: 11998880

2

Differential CXC and CX3C Chemokine Expression Profiles in Aqueous Humor of Patients With Specific Endogenous Uveitic Entities.

El-Asrar AMA, Berghmans N, Al-Obeidan SA, Gikandi PW, Opdenakker G, Van Damme J, Struyf S. El-Asrar AMA, et al. Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2222-2228. doi: 10.1167/iovs.17-23225. Invest Ophthalmol Vis Sci. 2018. PMID: 29715366

3

Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.

El-Asrar AM, Missotten L, Geboes K. El-Asrar AM, et al. Mol Vis. 2011 Feb 17;17:508-18. Mol Vis. 2011. PMID: 21365018 Free PMC article.

4

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.

El-Asrar AM, Nawaz MI, Kangave D, Geboes K, Ola MS, Ahmad S, Al-Shabrawey M. El-Asrar AM, et al. Mol Vis. 2011;17:1829-38. Epub 2011 Jul 6. Mol Vis. 2011. PMID: 21850157 Free PMC article.

5

Role of inflammation in the pathogenesis of diabetic retinopathy.

El-Asrar AM. El-Asrar AM. Middle East Afr J Ophthalmol. 2012 Jan;19(1):70-4. doi: 10.4103/0974-9233.92118. Middle East Afr J Ophthalmol. 2012. PMID: 22346117 Free PMC article.

6

Pharmacologic vitreolysis in diabetic retinopathy.

El-Asrar AM, Al-Mezain HS. El-Asrar AM, et al. Curr Pharm Biotechnol. 2011 Mar 1;12(3):406-9. doi: 10.2174/138920111794480543. Curr Pharm Biotechnol. 2011. PMID: 20939804 Review.

7

A clinical approach to the diagnosis of retinal vasculitis.

El-Asrar AM, Herbort CP, Tabbara KF. El-Asrar AM, et al. Int Ophthalmol. 2010 Apr;30(2):149-73. doi: 10.1007/s10792-009-9301-3. Epub 2009 Feb 4. Int Ophthalmol. 2010. PMID: 19190857 Review.

8

Changing paradigms in the treatment of diabetic retinopathy.

El-Asrar AM, Al-Mezaine HS, Ola MS. El-Asrar AM, et al. Curr Opin Ophthalmol. 2009 Nov;20(6):532-8. doi: 10.1097/ICU.0b013e328330b533. Curr Opin Ophthalmol. 2009. PMID: 19644368 Review.

9

Sympathetic ophthalmia after complicated cataract surgery and intraocular lens implantation.

El-Asrar AM, Al-Obeidan SA. El-Asrar AM, et al. Eur J Ophthalmol. 2001 Apr-Jun;11(2):193-6. doi: 10.1177/112067210101100218. Eur J Ophthalmol. 2001. PMID: 11456026

10

Ocular levels of azithromycin.

Tabbara KF, al-Kharashi SA, al-Mansouri SM, al-Omar OM, Cooper H, el-Asrar AM, Foulds G. Tabbara KF, et al. Arch Ophthalmol. 1998 Dec;116(12):1625-8. doi: 10.1001/archopht.116.12.1625. Arch Ophthalmol. 1998. PMID: 9869792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results